These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 37519823)
1. Partial preservation of the normal thyroid gland based on tumor diameter may be possible in small medullary thyroid carcinoma: a two-center 15-year retrospective study. Fu G; Li X; Guo F; Ruan X; Zhang W; Zhang W; Zhang Y; Chen Y; Li C; Chen J; Zheng X; Wang Z; Gao M Front Oncol; 2023; 13():1216394. PubMed ID: 37519823 [TBL] [Abstract][Full Text] [Related]
2. Incidental T1 stage medullary thyroid carcinoma: The effect of tumour diameter on prognosis and therapeutic implications. Gui Z; Wang Z; Xiang J; Sun W; He L; Dong W; Huang J; Zhang D; Lv C; Zhang T; Shao L; Zhang P; Zhang H Clin Endocrinol (Oxf); 2022 Sep; 97(3):355-362. PubMed ID: 35192214 [TBL] [Abstract][Full Text] [Related]
3. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Kebebew E; Ituarte PH; Siperstein AE; Duh QY; Clark OH Cancer; 2000 Mar; 88(5):1139-48. PubMed ID: 10699905 [TBL] [Abstract][Full Text] [Related]
4. [Risk factors of recurrence or metastasis in patients with medullary thyroid carcinoma]. Guo FL; Li LJ; Ruan XH; Fu GM; Zhao JZ; Hou XK; Gao M; Zheng XQ Zhonghua Yi Xue Za Zhi; 2022 Dec; 102(48):3849-3855. PubMed ID: 36540922 [No Abstract] [Full Text] [Related]
5. SHOULD MULTIFOCAL PAPILLARY THYROID CARCINOMAS CLASSIFIED AS T1A WITH A TUMOR DIAMETER SUM OF 1 TO 2 CENTIMETERS BE RECLASSIFIED AS T1B? Tam AA; Ozdemir D; Ogmen BE; Fakı S; Dumlu EG; Yazgan AK; Ersoy R; Cakır B Endocr Pract; 2017 May; 23(5):526-535. PubMed ID: 28156153 [TBL] [Abstract][Full Text] [Related]
6. Does the T1 subdivision correlate with the risk of recurrence of papillary thyroid cancer? Chereau N; Trésallet C; Noullet S; Godiris-Petit G; Tissier F; Leenhardt L; Menegaux F Langenbecks Arch Surg; 2016 Mar; 401(2):223-30. PubMed ID: 26957089 [TBL] [Abstract][Full Text] [Related]
7. An Undetectable Postoperative Calcitonin Level Is Associated with Long-Term Disease-Free Survival in Medullary Thyroid Carcinoma: Results of a Retrospective Cohort Study. Duval MADS; Ferreira CV; Marmitt L; Dora JM; Espíndola M; Benini AF; Camelier MV; Bulzico D; Andrade FA; Alves Júnior PA; Corbo R; Vaisman F; Zanella AB; Scheffel RS; Maia AL Thyroid; 2023 Jan; 33(1):82-90. PubMed ID: 36222615 [No Abstract] [Full Text] [Related]
8. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience. Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924 [TBL] [Abstract][Full Text] [Related]
9. Prophylactic thyroidectomy for MEN 2-related medullary thyroid carcinoma based on predictive testing for RET proto-oncogene mutation and basal serum calcitonin in China. Qi XP; Zhao JQ; Du ZF; Yang RR; Ma JM; Fei J; Cheng J; Han JS; Jin HY; Chen ZG; Wang JQ; Yang YP; Ying RB; Chen XL; Liu WT; Zhao Y; Jiang HL; Zhang XN Eur J Surg Oncol; 2013 Sep; 39(9):1007-12. PubMed ID: 23849459 [TBL] [Abstract][Full Text] [Related]
10. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines. Mitchell AL; Gandhi A; Scott-Coombes D; Perros P J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128 [TBL] [Abstract][Full Text] [Related]
11. Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center. Kim SJ; Yun HJ; Shin SJ; Lee YS; Chang HS Front Endocrinol (Lausanne); 2021; 12():747704. PubMed ID: 34803914 [TBL] [Abstract][Full Text] [Related]
12. Results of Surgical Therapy in Patients with Medullary Thyroid Carcinoma. Vlad M; Zosin I; Timar B; Lazar F; Vlad A; Timar R; Cornianu M Indian J Surg; 2016 Aug; 78(4):309-14. PubMed ID: 27574350 [TBL] [Abstract][Full Text] [Related]
13. Medullary Thyroid Carcinoma: Prognostic Variables And Tumour Markers Affecting Survival. Hassan A; Siddique M; Riaz S; Khan AI; Nawaz MK; Bashir H J Ayub Med Coll Abbottabad; 2018; 30(Suppl 1)(4):S627-S632. PubMed ID: 30838820 [TBL] [Abstract][Full Text] [Related]
14. Medullary thyroid cancer: clinico-pathological profile and outcome in a tertiary care center in North India. Mehrotra PK; Mishra A; Mishra SK; Agarwal G; Agarwal A; Verma AK World J Surg; 2011 Jun; 35(6):1273-80. PubMed ID: 21479684 [TBL] [Abstract][Full Text] [Related]
15. Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B. Skinner MA; DeBenedetti MK; Moley JF; Norton JA; Wells SA J Pediatr Surg; 1996 Jan; 31(1):177-81; discussion 181-2. PubMed ID: 8632274 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules. Rieu M; Lame MC; Richard A; Lissak B; Sambort B; Vuong-Ngoc P; Berrod JL; Fombeur JP Clin Endocrinol (Oxf); 1995 May; 42(5):453-60. PubMed ID: 7621562 [TBL] [Abstract][Full Text] [Related]
17. Distant metastasis in medullary thyroid carcinoma: Clinical outcomes and implications of T stage. Shao Y; Li G; Wei T; Gong R; Li Z; Zhu J; Lei J Clin Endocrinol (Oxf); 2022 Nov; 97(5):676-684. PubMed ID: 35261045 [TBL] [Abstract][Full Text] [Related]
18. Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer. Scollo C; Baudin E; Travagli JP; Caillou B; Bellon N; Leboulleux S; Schlumberger M J Clin Endocrinol Metab; 2003 May; 88(5):2070-5. PubMed ID: 12727956 [TBL] [Abstract][Full Text] [Related]